rawfin.tv
ANI Pharmaceuticals CFO Sells $240,000 in Stock Following Cortrophin Surge
MarketsstocksAI Generated

ANI Pharmaceuticals CFO Sells $240,000 in Stock Following Cortrophin Surge

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Stephen Carey, CFO of ANI Pharmaceuticals, sold 2,850 shares of common stock valued at $239,742. The sale was part of a pre-scheduled plan and occurred after a 42% surge in Cortrophin.

ANIPPharmaceuticalsInsider TradingStock Performance

Related Articles

Meta Launches $35 Billion Stock Offering for AI Infrastructure

Meta Launches $35 Billion Stock Offering for AI Infrastructure

stocks
EQT Acquires Range Resources in $50 Billion All-Stock Transaction

EQT Acquires Range Resources in $50 Billion All-Stock Transaction

stocks
Nasdaq Drops Nearly 700 Points While Traders Assess History

Nasdaq Drops Nearly 700 Points While Traders Assess History

stocks
S&P 500 Heavyweights Face Earnings Test Amid Fed Meeting

S&P 500 Heavyweights Face Earnings Test Amid Fed Meeting

stocks